A rock and a hard place: The selective serotonin reuptake inhibitor dilemmas in addressing perinatal mood and anxiety disorders

Abstract: Untreated perinatal depression and anxiety increase the risk of pregnancy complications, introducing significant maternal and neonatal complications. Unfortunately, antidepressant treatment with selective serotonin reuptake inhibitors (SSRIs) is similarly associated with adverse perinatal outcomes. Providers should consider all maternal and fetal outcomes when addressing this dilemma.

*Corresponding Author: 

Hindi Stohl, MD, Department of Obstetrics and Gynecology, Harbor UCLA Medical Center, 1000 West Carson Street, Box 3, Torrance, CA 90502. USA. Tel.: +1 310 222 3568; +1 310 222 7202; E-mail: hindistohl@gmail.com.